The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells

Kanae Bekki, Helena Vogel, Wen Li, Tomohiro Ito, Colleen A Sweeney, Thomas Haarmann-Stemmann, Fumio Matsumura, Christoph F A Vogel

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The aryl hydrocarbon receptor (AhR) is well known as a ligand binding transcription factor regulating various biological effects. Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer. In this study, we studied the anti-apoptotic role of AhR in different breast cancer cells when apoptosis was induced by exposure to UV light and chemotherapeutic agents. Activation of AhR by 2,3,7,8-tetrachlorodibenzo-. p-dioxin (TCDD) in AhR overexpressing breast cancer cells effectively suppressed the apoptotic response induced by UV-irradiation, doxorubicin, lapatinib and paclitaxel. The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity. Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells. Accordingly, our present study suggests that AhR plays a pivotal role in the development of breast cancer via the suppression of apoptosis, and provides an idea that the use of AhR antagonists with chemotherapeutic agents may effectively synergize the elimination of breast cancer cells.

Original languageEnglish (US)
Pages (from-to)5-13
Number of pages9
JournalPesticide Biochemistry and Physiology
Volume120
DOIs
StatePublished - May 1 2015

Fingerprint

Aryl Hydrocarbon Receptors
breast neoplasms
hydrocarbons
apoptosis
Apoptosis
Breast Neoplasms
receptors
kynurenine
Kynurenine
antagonists
neoplasm cells
Indoleamine-Pyrrole 2,3,-Dioxygenase
Ligands
immunosuppressive agents
doxorubicin
paclitaxel
dioxins
prostaglandin synthase
Cyclooxygenase 2
chronic exposure

Keywords

  • AhR
  • Apoptosis
  • Breast cancer
  • IDO
  • NF-κB
  • TCDD

ASJC Scopus subject areas

  • Agronomy and Crop Science
  • Health, Toxicology and Mutagenesis

Cite this

The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells. / Bekki, Kanae; Vogel, Helena; Li, Wen; Ito, Tomohiro; Sweeney, Colleen A; Haarmann-Stemmann, Thomas; Matsumura, Fumio; Vogel, Christoph F A.

In: Pesticide Biochemistry and Physiology, Vol. 120, 01.05.2015, p. 5-13.

Research output: Contribution to journalArticle

Bekki, Kanae ; Vogel, Helena ; Li, Wen ; Ito, Tomohiro ; Sweeney, Colleen A ; Haarmann-Stemmann, Thomas ; Matsumura, Fumio ; Vogel, Christoph F A. / The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells. In: Pesticide Biochemistry and Physiology. 2015 ; Vol. 120. pp. 5-13.
@article{6efda8034d3c460a956d9a2d11b3243e,
title = "The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells",
abstract = "The aryl hydrocarbon receptor (AhR) is well known as a ligand binding transcription factor regulating various biological effects. Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer. In this study, we studied the anti-apoptotic role of AhR in different breast cancer cells when apoptosis was induced by exposure to UV light and chemotherapeutic agents. Activation of AhR by 2,3,7,8-tetrachlorodibenzo-. p-dioxin (TCDD) in AhR overexpressing breast cancer cells effectively suppressed the apoptotic response induced by UV-irradiation, doxorubicin, lapatinib and paclitaxel. The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity. Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells. Accordingly, our present study suggests that AhR plays a pivotal role in the development of breast cancer via the suppression of apoptosis, and provides an idea that the use of AhR antagonists with chemotherapeutic agents may effectively synergize the elimination of breast cancer cells.",
keywords = "AhR, Apoptosis, Breast cancer, IDO, NF-κB, TCDD",
author = "Kanae Bekki and Helena Vogel and Wen Li and Tomohiro Ito and Sweeney, {Colleen A} and Thomas Haarmann-Stemmann and Fumio Matsumura and Vogel, {Christoph F A}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.pestbp.2014.12.021",
language = "English (US)",
volume = "120",
pages = "5--13",
journal = "Pesticide Biochemistry and Physiology",
issn = "0048-3575",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells

AU - Bekki, Kanae

AU - Vogel, Helena

AU - Li, Wen

AU - Ito, Tomohiro

AU - Sweeney, Colleen A

AU - Haarmann-Stemmann, Thomas

AU - Matsumura, Fumio

AU - Vogel, Christoph F A

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The aryl hydrocarbon receptor (AhR) is well known as a ligand binding transcription factor regulating various biological effects. Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer. In this study, we studied the anti-apoptotic role of AhR in different breast cancer cells when apoptosis was induced by exposure to UV light and chemotherapeutic agents. Activation of AhR by 2,3,7,8-tetrachlorodibenzo-. p-dioxin (TCDD) in AhR overexpressing breast cancer cells effectively suppressed the apoptotic response induced by UV-irradiation, doxorubicin, lapatinib and paclitaxel. The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity. Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells. Accordingly, our present study suggests that AhR plays a pivotal role in the development of breast cancer via the suppression of apoptosis, and provides an idea that the use of AhR antagonists with chemotherapeutic agents may effectively synergize the elimination of breast cancer cells.

AB - The aryl hydrocarbon receptor (AhR) is well known as a ligand binding transcription factor regulating various biological effects. Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer. In this study, we studied the anti-apoptotic role of AhR in different breast cancer cells when apoptosis was induced by exposure to UV light and chemotherapeutic agents. Activation of AhR by 2,3,7,8-tetrachlorodibenzo-. p-dioxin (TCDD) in AhR overexpressing breast cancer cells effectively suppressed the apoptotic response induced by UV-irradiation, doxorubicin, lapatinib and paclitaxel. The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity. Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells. Accordingly, our present study suggests that AhR plays a pivotal role in the development of breast cancer via the suppression of apoptosis, and provides an idea that the use of AhR antagonists with chemotherapeutic agents may effectively synergize the elimination of breast cancer cells.

KW - AhR

KW - Apoptosis

KW - Breast cancer

KW - IDO

KW - NF-κB

KW - TCDD

UR - http://www.scopus.com/inward/record.url?scp=84929505017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929505017&partnerID=8YFLogxK

U2 - 10.1016/j.pestbp.2014.12.021

DO - 10.1016/j.pestbp.2014.12.021

M3 - Article

C2 - 25987214

AN - SCOPUS:84929505017

VL - 120

SP - 5

EP - 13

JO - Pesticide Biochemistry and Physiology

JF - Pesticide Biochemistry and Physiology

SN - 0048-3575

ER -